Aarti Kawatkar

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Top Venues

ACS chemical biology

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Heng Zhao, Praveen Kumar, Tiago Jose Paschoal Sobreira, Mackenzie Smith, Steven Novick, Anders Johansson, Anna Luchniak, Andrew X Zhang, Kevin J Woollard, Niklas Larsson, Aarti Kawatkar
Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3. ACS chemical biology 19 (4) (2024)
Heng Zhao, Praveen Kumar, Tiago Jose Paschoal Sobreira, Mackenzie Smith, Steven Novick, Anders Johansson, Anna Luchniak, Andrew X Zhang, Kevin J Woollard, Niklas Larsson, Aarti Kawatkar
Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3. ACS chemical biology 19 (4) (2024)
Heng Zhao, Praveen Kumar, Tiago Jose Paschoal Sobreira, Mackenzie Smith, Steven Novick, Anders Johansson, Anna Luchniak, Andrew X Zhang, Kevin J Woollard, Niklas Larsson, Aarti Kawatkar
Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3. ACS chemical biology 19 (4) (2024)
Heng Zhao, Praveen Kumar, Tiago Jose Paschoal Sobreira, Mackenzie Smith, Steven Novick, Anders Johansson, Anna Luchniak, Andrew X Zhang, Kevin J Woollard, Niklas Larsson, Aarti Kawatkar
Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3. ACS chemical biology 19 (4) (2024)
Heng Zhao, Praveen Kumar, Tiago Jose Paschoal Sobreira, Mackenzie Smith, Steven Novick, Anders Johansson, Anna Luchniak, Andrew X Zhang, Kevin J Woollard, Niklas Larsson, Aarti Kawatkar
Integrated Proteomics Characterization of NLRP3 Inflammasome Inhibitor MCC950 in Monocytic Cell Line Confirms Direct MCC950 Engagement with Endogenous NLRP3. ACS chemical biology (2024)
Aarti Kawatkar, Roger A Clark, Lorna Hopcroft, Debora Ann Roaquin, Ronald Tomlinson, Andrea M Zuhl, Gillian M Lamont, Jason G Kettle, Susan E Critchlow, M Paola Castaldi, Frederick W Goldberg, Andrew X Zhang
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. ACS chemical biology 18 (2) (2023)
Aarti Kawatkar, Roger A Clark, Lorna Hopcroft, Debora Ann Roaquin, Ronald Tomlinson, Andrea M Zuhl, Gillian M Lamont, Jason G Kettle, Susan E Critchlow, M Paola Castaldi, Frederick W Goldberg, Andrew X Zhang
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. ACS chemical biology 18 (2) (2023)
Aarti Kawatkar, Roger A Clark, Lorna Hopcroft, Debora Ann Roaquin, Ronald Tomlinson, Andrea M Zuhl, Gillian M Lamont, Jason G Kettle, Susan E Critchlow, M Paola Castaldi, Frederick W Goldberg, Andrew X Zhang
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. ACS chemical biology 18 (2) (2023)
Aarti Kawatkar, Roger A Clark, Lorna Hopcroft, Debora Ann Roaquin, Ronald Tomlinson, Andrea M Zuhl, Gillian M Lamont, Jason G Kettle, Susan E Critchlow, M Paola Castaldi, Frederick W Goldberg, Andrew X Zhang
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. ACS chemical biology 18 (2) (2023)
Aarti Kawatkar, Roger A Clark, Lorna Hopcroft, Debora Ann Roaquin, Ronald Tomlinson, Andrea M Zuhl, Gillian M Lamont, Jason G Kettle, Susan E Critchlow, M Paola Castaldi, Frederick W Goldberg, Andrew X Zhang
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. ACS chemical biology (2023)
Aarti Kawatkar, Roger A Clark, Lorna Hopcroft, Debora Ann Roaquin, Ronald Tomlinson, Andrea M Zuhl, Gillian M Lamont, Jason G Kettle, Susan E Critchlow, M Paola Castaldi, Frederick W Goldberg, Andrew X Zhang
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. ACS chemical biology (2023)
Aarti Kawatkar, Roger A Clark, Lorna Hopcroft, Debora Ann Roaquin, Ronald Tomlinson, Andrea M Zuhl, Gillian M Lamont, Jason G Kettle, Susan E Critchlow, M Paola Castaldi, Frederick W Goldberg, Andrew X Zhang
Chemical Biology Approaches Confirm MCT4 as the Therapeutic Target of a Cellular Optimized Hit. ACS chemical biology (2023)
Frederick W Goldberg, Jason G Kettle, Gillian M Lamont, David Buttar, Attilla K T Ting, Thomas M McGuire, Calum R Cook, David Beattie, Pablo Morentin Gutierrez, Stefan L Kavanagh, Jasper C Komen, Aarti Kawatkar, Roger Clark, Lorna Hopcroft, Gareth Hughes, Susan E Critchlow
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. Journal of medicinal chemistry 66 (1) (2022)
Frederick W Goldberg, Jason G Kettle, Gillian M Lamont, David Buttar, Attilla K T Ting, Thomas M McGuire, Calum R Cook, David Beattie, Pablo Morentin Gutierrez, Stefan L Kavanagh, Jasper C Komen, Aarti Kawatkar, Roger Clark, Lorna Hopcroft, Gareth Hughes, Susan E Critchlow
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. Journal of medicinal chemistry 66 (1) (2022)
Frederick W Goldberg, Jason G Kettle, Gillian M Lamont, David Buttar, Attilla K T Ting, Thomas M McGuire, Calum R Cook, David Beattie, Pablo Morentin Gutierrez, Stefan L Kavanagh, Jasper C Komen, Aarti Kawatkar, Roger Clark, Lorna Hopcroft, Gareth Hughes, Susan E Critchlow
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. Journal of medicinal chemistry 66 (1) (2022)
Frederick W Goldberg, Jason G Kettle, Gillian M Lamont, David Buttar, Attilla K T Ting, Thomas M McGuire, Calum R Cook, David Beattie, Pablo Morentin Gutierrez, Stefan L Kavanagh, Jasper C Komen, Aarti Kawatkar, Roger Clark, Lorna Hopcroft, Gareth Hughes, Susan E Critchlow
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. Journal of medicinal chemistry (2022)